DSpace Repository

Advanced Glycation End Products and Their Adverse Effects: The Role of Autophagy

Show simple item record

dc.contributor.author Sruthi, C R
dc.contributor.author Raghu, K G
dc.date.accessioned 2023-01-18T06:34:57Z
dc.date.available 2023-01-18T06:34:57Z
dc.date.issued 2021-03
dc.identifier.citation Journal of Biochemical and Molecular Toxicology: 35(4): e22710 en_US
dc.identifier.uri https://doi.org/10.1002/jbt.22710
dc.identifier.uri http://localhost:8080/xmlui/handle/123456789/4187
dc.description.abstract The critical roles played by advanced glycation endproducts (AGEs) accumulation in diabetes and diabetic complications have gained intense recognition. AGEs interfere with the normal functioning of almost every organ with multiple actions like apoptosis, inflammation, protein dysfunction, mitochondrial dysfunction, and oxidative stress. However, the development of a potential treatment strategy is yet to be established. Autophagy is an evolutionarily conserved cellular process that maintains cellular homeostasis with the degradation and recycling systems. AGEs can activate autophagy signaling, which could be targeted as a therapeutic strategy against AGEs induced problems. In this review, we have provided an overview of the adverse effects of AGEs, and we put forth the notion that autophagy could be a promising targetable strategy against AGEs. en_US
dc.language.iso en en_US
dc.publisher Wiley en_US
dc.subject advanced glycation end products (AGEs) en_US
dc.subject AGEs‐RAGE axis en_US
dc.subject autophagy en_US
dc.subject diabetic complications en_US
dc.subject RAGE en_US
dc.title Advanced Glycation End Products and Their Adverse Effects: The Role of Autophagy en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

  • 2021
    Research articles authored by NIIST researchers published in 2021

Show simple item record

Search DSpace


Advanced Search

Browse

My Account